A-FABP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of A-FABP monoclonal antibodies for research focused on adipocyte fatty acid-binding protein (A-FABP) in various biological processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). A-FABP plays a central role in lipid metabolism and energy homeostasis, significantly influencing insulin sensitivity and inflammation. Research has shown that A-FABP expression correlates strongly with obesity and metabolic disorders, making it an important focus for metabolic disease studies and therapeutic development. Scientists worldwide utilize A-FABP monoclonal antibodies to advance their understanding of lipid metabolism pathways. Current research with A-FABP monoclonal antibodies continues to reveal new insights into metabolic regulation and potential treatment strategies. Ongoing studies demonstrate the importance of A-FABP in maintaining metabolic balance and its impact on various health conditions. Laboratory investigations with A-FABP monoclonal antibodies have contributed significantly to our knowledge of cellular metabolism and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for A-FABP research support scientists in making meaningful discoveries that advance our understanding of metabolic health and disease.